T. Rowe Price Associates’s Mercury Insurance MCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.04M Buy
34,474
+6,919
+25% +$619K ﹤0.01% 1642
2025
Q4
$2.59M Buy
27,555
+862
+3% +$74.8K ﹤0.01% 1642
2025
Q3
$2.26M Buy
26,693
+471
+2% +$34.8K ﹤0.01% 1680
2025
Q2
$1.77M Buy
26,222
+1,538
+6% +$91.5K ﹤0.01% 1691
2025
Q1
$1.38M Buy
24,684
+343
+1% +$18.5K ﹤0.01% 1785
2024
Q4
$1.62M Buy
24,341
+1,765
+8% +$124K ﹤0.01% 1744
2024
Q3
$1.42M Buy
22,576
+228
+1% +$13.5K ﹤0.01% 1797
2024
Q2
$1.19M Buy
22,348
+658
+3% +$35.6K ﹤0.01% 1824
2024
Q1
$1.12M Buy
21,690
+937
+5% +$41.3K ﹤0.01% 1864
2023
Q4
$775K Sell
20,753
-90
-0.4% -$3.12K ﹤0.01% 1992
2023
Q3
$585K Buy
20,843
+2,328
+13% +$68.7K ﹤0.01% 2031
2023
Q2
$561K Buy
18,515
+455
+3% +$13.9K ﹤0.01% 2076
2023
Q1
$574K Buy
18,060
+5,928
+49% +$202K ﹤0.01% 2048
2022
Q4
$415K Sell
12,132
-1,778
-13% -$59.1K ﹤0.01% 2218
2022
Q3
$396K Sell
13,910
-7,472
-35% -$271K ﹤0.01% 2245
2022
Q2
$947K Buy
21,382
+1,029
+5% +$50.9K ﹤0.01% 1924
2022
Q1
$1.12M Buy
20,353
+258
+1% +$13.9K ﹤0.01% 1949
2021
Q4
$1.07M Sell
20,095
-464
-2% -$24.9K ﹤0.01% 2006
2021
Q3
$1.15M Sell
20,559
-41
-0.2% -$2.45K ﹤0.01% 1989
2021
Q2
$1.34M Buy
20,600
+253
+1% +$16K ﹤0.01% 1930
2021
Q1
$1.24M Sell
20,347
-3,689
-15% -$211K ﹤0.01% 1949
2020
Q4
$1.25M Sell
24,036
-12,174
-34% -$544K ﹤0.01% 1838
2020
Q3
$1.5M Sell
36,210
-2,060
-5% -$88.5K ﹤0.01% 1641
2020
Q2
$1.56M Sell
38,270
-5,080
-12% -$204K ﹤0.01% 1609
2020
Q1
$1.76M Buy
43,350
+6,621
+18% +$302K ﹤0.01% 1535
2019
Q4
$1.79M Sell
36,729
-276
-0.7% -$13.9K ﹤0.01% 1641
2019
Q3
$2.07M Buy
37,005
+4,864
+15% +$278K ﹤0.01% 1568
2019
Q2
$2.01M Buy
32,141
+1,931
+6% +$108K ﹤0.01% 1594
2019
Q1
$1.51M Buy
30,210
+1,760
+6% +$91.4K ﹤0.01% 1682
2018
Q4
$1.47M Sell
28,450
-8,070
-22% -$439K ﹤0.01% 1652
2018
Q3
$1.83M Buy
36,520
+5,892
+19% +$294K ﹤0.01% 1649
2018
Q2
$1.4M Buy
30,628
+122
+0.4% +$5.75K ﹤0.01% 1701
2018
Q1
$1.4M Buy
30,506
+97
+0.3% +$4.62K ﹤0.01% 1666
2017
Q4
$1.63M Buy
30,409
+2,250
+8% +$124K ﹤0.01% 1635
2017
Q3
$1.6M Sell
28,159
-3,400
-11% -$193K ﹤0.01% 1626
2017
Q2
$1.7M Sell
31,559
-4,300
-12% -$244K ﹤0.01% 1592
2017
Q1
$2.19M Buy
35,859
+15,199
+74% +$908K ﹤0.01% 1554
2016
Q4
$1.24M Buy
20,660
+8
+0% +$455 ﹤0.01% 1702
2016
Q3
$1.13M Hold
20,652
﹤0.01% 1695
2016
Q2
$1.1M Buy
20,652
+3,400
+20% +$179K ﹤0.01% 1680
2016
Q1
$957K Buy
17,252
+1,400
+9% +$69.8K ﹤0.01% 1719
2015
Q4
$738K Buy
15,852
+59
+0.4% +$2.99K ﹤0.01% 1795
2015
Q3
$798K Sell
15,793
-1,400
-8% -$75K ﹤0.01% 1773
2015
Q2
$957K Buy
17,193
+1,700
+11% +$95.7K ﹤0.01% 1762
2015
Q1
$895K Sell
15,493
-1,800
-10% -$101K ﹤0.01% 1769
2014
Q4
$980K Sell
17,293
-900
-5% -$48.2K ﹤0.01% 1728
2014
Q3
$888K Sell
18,193
-1,900
-9% -$93.8K ﹤0.01% 1761
2014
Q2
$945K Buy
20,093
+4,300
+27% +$202K ﹤0.01% 1743
2014
Q1
$712K Hold
15,793
﹤0.01% 1787
2013
Q4
$785K Hold
15,793
﹤0.01% 1742
2013
Q3
$763K Buy
15,793
+700
+5% +$31.6K ﹤0.01% 1746
2013
Q2
$663K Buy
+15,093
New +$649K ﹤0.01% 1770

Other funds holding MCY

T. Rowe Price Associates's MCY Position: Q1 2026 in Review

T. Rowe Price Associates increased its Mercury Insurance (MCY) stake by 25% in Q1 2026, buying an estimated $619K and bringing the position to 34,474 shares worth $3.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1642.

T. Rowe Price Associates first reported a position in MCY in Q2 2013 and has held it in 52 quarters since. 306 funds tracked by Wall St. Rank hold MCY as of Q1 2026.

  • T. Rowe Price Associates held 34,474 shares of Mercury Insurance worth $3.04M as of Q1 2026.
  • T. Rowe Price Associates bought 6,919 Mercury Insurance shares in Q1 2026, an estimated $619K.
  • Mercury Insurance made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1642 holding.
  • T. Rowe Price Associates first reported a position in Mercury Insurance in Q2 2013 and has held it in 52 quarters since.
  • 306 funds tracked by Wall St. Rank held Mercury Insurance as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.